Nevertheless the endocannabinoid program is difficult instead of nevertheless perfectly comprehended; no person has but administered endocannabinoids to people today, leaving what Mechoulam sees as a gaping gap of knowledge, and a large opportunity. “I believe that we're lacking a lot,” he says.When Raphael Mechoulam, then a younger chemist in